Transcatheter aortic valve replacement in patients with quadricuspid aortic valve in a single center.

ABSTRACT:

Background

Quadricuspid aortic valve (QAV) is a rare congenital malformation that can present with aortic regurgitation or aortic stenosis (AS)), requiring surgical treatment. Transcatheter aortic valve replacement (TAVR) is an alternative treatment for older patients and its prognosis for QAV therapy remains challenging. We sought to examine our early experience with TAVR in patients with QAV.

Materials and methods

Prospectively collected data were retrospectively reviewed in patients with QAV undergoing TAVR in our institution.

Results

Five patients with QAV and AR or AS were treated with TAVR between January 2016 and January 2022. The mean age was 73.8 years (range 69-82 years), and the median Society of Thoracic Surgeons score was 7.51% (range 2.668-18.138%). Two

SUBMITTER: Liu Y 

PROVIDER: S-EPMC9554142 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature